Author

Claudia Bigas

Institute for Research in Biomedicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Ali ShilatifardiD· 1 shared Eita UchidaiD· 1 shared Jun WatanabeiD· 1 shared Kentaro Mineji· 1 shared Luke St JohniD· 1 shared Marta IwanaszkoiD· 1 shared Meenal Karunanidhi· 1 shared Rama K. MishraiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Ali ShilatifardORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

FCD-11: A First-in-Class COMPASS Inhibitor in Cancer Therapeutics

Zibo Zhao, Meenal Karunanidhi, Sarah R. Gold, Luke St John, Rukkia Liaqat, Marta Iwanaszko, Claudia Bigas, Eita Uchida, Kentaro Mineji, Jun Watanabe, Salvador Aznar-Benitah, Rintaro Hashizume, Rama K. Mishra, Ali Shilatifard

The paper identifies and characterizes FCD-11, a first-in-class COMPASS inhibitor that reduces tumor size and extends survival in breast cancer models.

bioRxiv · Jul 31, 2026 · PreprintBiochemistry